Internal Medicine, Infectious Disease · Memphis, TN
NPI
1396921623
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1325 Eastmoreland Ave Ste 360
Memphis, TN, 38104
Phone (901) 516-8714
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
201 services
Medicare patients, 2024
105
Average age 68
Drug cost, 2024
$4.6M
1,865 prescriptions
Company payments, 2025
$1,481
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shirin Mazumder was code 99213 (office e&m - established), 76 times for 55 patients. In total Shirin Mazumder billed 201 services in 11 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 76 | 55 | $37.71 | $2,866 |
| 99213 Office E&M - Established | Office | 42 | 32 | $44.94 | $1,888 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 20 | 19 | $11.56 | $231 |
| 99214 Office E&M - Established | Facility | 15 | 14 | $66.34 | $995 |
| 99214 Office E&M - Established | Office | 15 | 14 | $56.26 | $844 |
By year: 2022 $14K for 252 services; 2023 $14K for 233 services; 2024 $10K for 201 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shirin Mazumder prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 485 prescriptions and refills. In total Shirin Mazumder wrote 1,865 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 485 | 501 | 53 | $2.0M |
| Tivicay Dolutegravir Sodium | 200 | 200 | 20 | $515K |
| Pifeltro Doravirine | 163 | 171 | 18 | $322K |
| Doxycycline Hyclate Generic | 92 | 103 | 29 | $2,150 |
| Descovy Emtricitabine/Tenofov Alafenam | 92 | 92 | Under 11 | $221K |
| Dovato Dolutegravir Sodium/Lamivudine | 85 | 85 | Under 11 | $263K |
| Juluca Dolutegravir/Rilpivirine | 65 | 65 | Under 11 | $241K |
| Cephalexin Generic | 58 | 74 | 15 | $1,079 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 54 | 78 | Under 11 | $297K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 45 | 63 | 14 | $432 |
| Minocycline Hcl Generic | 34 | 43 | Under 11 | $1,049 |
| Prezcobix Darunavir/Cobicistat | 33 | 33 | Under 11 | $85K |
| Amoxicillin Generic | 33 | 37 | Under 11 | $286 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 33 | 33 | Under 11 | $127K |
| Itraconazole Generic | 31 | 31 | Under 11 | $6,259 |
Brand drugs: 1,334 claims; generic drugs: 531 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shirin Mazumder $1,481 ($1,481 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $1,481.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 5 | $1,481 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.